Skip to main content
Have a personal or library account? Click to login
Epidemiologic Profile of Hypertension in Northern Iranian Population: The PERSIAN Guilan Cohort Study (PGCS) Cover

Epidemiologic Profile of Hypertension in Northern Iranian Population: The PERSIAN Guilan Cohort Study (PGCS)

Open Access
|Feb 2021

References

  1. Fan Wg, et al. The impact of changes in population blood pressure on hypertension prevalence and control in China. The Journal of Clinical Hypertension. 2020. DOI: 10.1111/jch.13820
  2. Torres JM, et al. Deportation worry, cardiovascular disease risk factor trajectories, and incident hypertension: A community-based cohort study. Journal of the American Heart Association. 2019; 8(23): e013086. DOI: 10.1161/JAHA.119.013086
  3. Fryar CD, et al. Hypertension prevalence and control among adults: United States, 2015–2016. 2017.
  4. Green AS, et al. Assessing providers’ approach to hypertension management at a large, private hospital in Kampala, Uganda. Ann Glob Health. 2020; 86(1): 5. DOI: 10.5334/aogh.2513
  5. Gong X, et al. Comparison of hypertension in migrant and local patients with atherosclerotic diseases: A cross-sectional study in Shanghai, China. Ann Glob Health. 2020; 86(1): 25. DOI: 10.5334/aogh.2635
  6. Pednekar M, et al. Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19.1 million participants. 2017.
  7. Liu B, et al. A comparison on prevalence of hypertension and related risk factors between island and rural residents of Dalian City, China. International Journal of Hypertension, 2019. DOI: 10.1155/2019/6413102
  8. Osman S, et al. Urbanization and socioeconomic disparities in hypertension among older adult women in Sudan. Annals of Global Health. 2019; 85(1): 29. DOI: 10.5334/aogh.2404
  9. Hajipour MJ, et al. Protocol design for large-scale cross-sectional studies of surveillance of risk factors of non-communicable diseases in Iran: STEPs 2016. Archives of Iranian Medicine. 2017; 20(9).
  10. Gholami A, et al. Is salt intake reduction a universal intervention for both normotensive and hypertensive people: A case from Iran STEPS survey 2016. European Journal of Nutrition. 2019: 113. DOI: 10.1007/s00394-019-02153-8
  11. Du M, et al. Self-reported hypertension in Northern China: A cross-sectional study of a risk prediction model and age trends. BMC Health Services Research. 2018; 18(1): 475. DOI: 10.1186/s12913-018-3279-3
  12. McDoom MM, et al. Late life socioeconomic status and hypertension in an aging cohort: The Atherosclerosis Risk in Communities Study. Journal of Hypertension. 2018; 36(6): 1382. DOI: 10.1097/HJH.0000000000001696
  13. Ghosh T, Ray MK. A case control study of the genetic and other risk factors of essential hypertension. International Journal of Research and Review. 2020; 7(1): 225230.
  14. Wu X, et al. The association between obesity indices and hypertension: Which index is the most notable indicator of hypertension in different age groups stratified by sex? Clinical and Experimental Hypertension. 2019; 41(4): 373380. DOI: 10.1080/10641963.2018.1489546
  15. Van NB, et al. Prevalence and risk factors of hypertension in the Vietnamese elderly. High Blood Pressure & Cardiovascular Prevention. 2019; 26(3): 239246. DOI: 10.1007/s40292-019-00314-8
  16. Kishore J, et al. Prevalence of hypertension and determination of its risk factors in rural Delhi. International Journal of Hypertension. 2016. DOI: 10.1155/2016/7962595
  17. Zanchetti A. From lifestyle changes to outcomes in hypertension. Journal of Hypertension. 2017; 35(11): 21212122. DOI: 10.1097/HJH.0000000000001542
  18. Ozemek C, et al. Impact of therapeutic lifestyle changes in resistant hypertension. Progress in Cardiovascular Diseases, 2019.
  19. Cook R, Lamont T, Martin R. Lifestyle changes may be more important than drugs for mild hypertension. BMJ. 2019; 364: l571. DOI: 10.1136/bmj.l571
  20. Mansour-Ghanaei F, et al. The PERSIAN Guilan Cohort Study (PGCS). Archives of Iranian Medicine (AIM). 2019; 22(1).
  21. Eghtesad S, et al. The PERSIAN cohort: Providing the evidence needed for healthcare reform. Archives of Iranian medicine. 2017; 20(11): 691.
  22. Poustchi H, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): Rationale, objectives, and design. American Journal of Epidemiology. 2017; 187(4): 647655. DOI: 10.1093/aje/kwx314
  23. Joukar F, et al. Validation of Omron HBP-1100-E professional blood pressure measuring device according to the American Association for the Advancement of Medical Instrumentation Protocol: The PERSIAN Guilan Cohort Study (PGCS). Medical Devices (Auckland, N.Z.). 2020; 13: 231236. DOI: 10.2147/MDER.S253638
  24. Joukar F, et al. Validity and inter-observers reliability of blood pressure measurements using mercury sphygmomanometer in the PERSIAN Guilan cohort study. Blood Press Monit. 2020; 25(2): 100104. DOI: 10.1097/MBP.0000000000000420
  25. Joukar F, et al. Association of serum levels of vitamin D with blood pressure status in Northern Iranian Population: The PERSIAN Guilan Cohort Study (PGCS). International Journal of General Medicine. 2020; 13: 99104. DOI: 10.2147/IJGM.S244472
  26. Hadaegh F, et al. Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes: 7.6 years follow-up in an Iranian population. International Journal of Obesity. 2009; 33(12): 14371445. DOI: 10.1038/ijo.2009.180
  27. Jensen M, et al. AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014; 129(25 Suppl 2): S13940. DOI: 10.1161/01.cir.0000437739.71477.ee
  28. Stone NJ, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2014; 63(25 Part B): 28892934.
  29. Bai SL, et al. Analysis of the first cluster of cases in a family of novel coronavirus pneumonia in Gansu Province. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 2020; 54: E005.
  30. Hypertension, T.F.f.t.M.o.A.H.o.t.E.S.o. Guidelines for the management of arterial hypertension. Eur Heart J. 2007; 28: 14621536.
  31. Malekzadeh MM, et al. Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. Journal of Hypertension. 2013; 31(7): 1364. DOI: 10.1097/HJH.0b013e3283613053
  32. Campos-Nonato I, et al. Prevalence, diagnosis and control of hypertension in Mexican adults with vulnerable condition. Results of the Ensanut 100k. Salud Pública de México. 2020; 61(6): 888897. DOI: 10.21149/10574
  33. Diemer FS, et al. Hypertension prevalence, awareness, treatment, and control in Surinamese living in Suriname and The Netherlands: The HELISUR and HELIUS studies. Internal and Emergency Medicine. 2020: 19.
  34. Khorrami Z, et al. The patterns of Non-communicable disease Multimorbidity in Iran: A multilevel analysis. Scientific Reports. 2020; 10(1): 111. DOI: 10.1038/s41598-020-59668-y
  35. Oori MJ, et al. Prevalence of HTN in Iran: Meta-analysis of published studies in 2004–2018. Current Hypertension Reviews. 2019; 15(2): 113122. DOI: 10.2174/1573402115666190118142818
  36. Gandomkar A, et al. Prevalence, Awareness, Treatment, Control, and Correlates of Hypertension in the Pars Cohort Study. Archives of Iranian Medicine (AIM). 2018; 21(8).
  37. Anto EO, et al. Prevalence and lifestyle-related risk factors of obesity and unrecognized hypertension among bus drivers in Ghana. Heliyon. 2020; 6(1): e03147. DOI: 10.1016/j.heliyon.2019.e03147
  38. Amiri P, et al. National trends of pre-hypertension and hypertension among Iranian adolescents across urban and rural areas (2007–2011). Biology of sex differences. 2019; 10(1): 15. DOI: 10.1186/s13293-019-0230-1
  39. Lamelas P, et al. Prevalence, awareness, treatment and control of hypertension in rural and urban communities in Latin American countries. Journal of Hypertension. 2019; 37(9): 18131821. DOI: 10.1097/HJH.0000000000002108
  40. Li W, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47,000 people from China. Journal of Hypertension. 2016; 34(1): 3946. DOI: 10.1097/HJH.0000000000000745
  41. Lankarani KB, Alavian SM, Peymani P. Health in the Islamic Republic of Iran, challenges and progresses. Medical Journal of the Islamic Republic of Iran. 2013; 27(1): 42.
  42. Sandberg K, Ji H. Sex differences in primary hypertension. Biology of Sex Differences. 2012; 3(1): 7. DOI: 10.1186/2042-6410-3-7
  43. Colafella KMM, Denton KM. Sex-specific differences in hypertension and associated cardiovascular disease. Nature Reviews Nephrology. 2018; 14(3): 185. DOI: 10.1038/nrneph.2017.189
  44. Jiang SZ, et al. Obesity and hypertension. Experimental and Therapeutic Medicine. 2016; 12(4): 23952399. DOI: 10.3892/etm.2016.3667
  45. Liu X, et al. Dose-response association between physical activity and incident hypertension: A systematic review and meta-analysis of cohort studies. Hypertension. 2017; 69(5): 813820. DOI: 10.1161/HYPERTENSIONAHA.116.08994
  46. Börjesson M, et al. Physical activity and exercise lower blood pressure in individuals with hypertension: Narrative review of 27 RCTs. Br J Sports Med. 2016; 50(6): 356361. DOI: 10.1136/bjsports-2015-095786
  47. Pescatello LS, et al. Physical activity to prevent and treat hypertension: A systematic review. Medicine & Science in Sports & Exercise. 2019; 51(6): 13141323. DOI: 10.1249/MSS.0000000000001943
  48. Booth H, Prevost A, Gulliford M. Severity of obesity and management of hypertension, hypercholesterolaemia and smoking in primary care: Population-based cohort study. Journal of human hypertension. 2016; 30(1): 4045.
  49. Strauss SM, et al. Clinicians’ panel management self-efficacy to support their patients’ smoking cessation and hypertension control needs. Translational behavioral medicine. 2015; 5(1): 6876.
  50. Gee ME, et al. Prevalence of, and barriers to, preventive lifestyle behaviors in hypertension (from a national survey of Canadians with hypertension). The American Journal of Cardiology. 2012; 109(4): 570575.
  51. De Boer IH, et al. Diabetes and hypertension: A position statement by the American Diabetes Association. Diabetes Care. 2017; 40(9): 12731284.
  52. Huang Y, et al. Association of all-cause and cardiovascular mortality with prehypertension: A meta-analysis. American Heart Journal. 2014; 167(2): 160168. e1.
  53. Bosworth HB, et al. The association of psychosocial factors and depression with hypertension among older adults. International Journal of Geriatric Psychiatry. 2003; 18(12): 11421148.
  54. Grimsrud A, et al. The association between hypertension and depression and anxiety disorders: results from a nationally-representative sample of South African adults. PloS one. 2009; 4(5).
  55. Stein DJ, et al. Associations between mental disorders and subsequent onset of hypertension. General Hospital Psychiatry. 2014; 36(2): 142149.
  56. Krtalic B, et al. Family history, blood pressure and life style. Results from EHUH study. Journal of Hypertension. 2019; 37: e230.
  57. van der Sande MA, et al. Family history: An opportunity for early interventions and improved control of hypertension, obesity and diabetes. Bulletin of the World Health Organization. 2001; 79: 321328.
  58. Lifton RP, et al. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nature Genetics. 1992; 2(1): 6674.
  59. Li A, et al. Association between family history and the onset age of essential hypertension in Han population in Shanghai, China. American Journal of Health Research. 2019; 7(5): 7984.
  60. Mourad J-J, et al. Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney International. 2001; 59(5): 18341841.
  61. Cui L-f, et al. Association of serum uric acid and risk of hypertension in adults: A prospective study of Kailuan Corporation cohort. Clinical Rheumatology. 2017; 36(5): 11031110.
DOI: https://doi.org/10.5334/aogh.3027 | Journal eISSN: 2214-9996
Language: English
Published on: Feb 12, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Mohammadreza Naghipour, Farahnaz Joukar, Arsalan Salari, Mehrnaz Asgharnezhad, Soheil Hassanipour, Fariborz Mansour-Ghanaei, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.